Despite the need for effective vancomycin therapy, there are few data guiding vancomycin monitoring in children. We reviewed retrospectively vancomycin use in children 1 month to 12 years of age. Initial and adjusted target trough vancomycin concentrations in serum were infrequently achieved regardless of the dosing schedule. Currently recommended trough concentrations need to be re-examined with a more detailed pharmacokinetic study in children.Claire L. Gordon, Chantelle Thompson, Jonathan R. Carapetis, John Turnidge, Charles Kilburn and Bart J. Curri
BACKGROUND Achieving therapeutic vancomycin concentrations in neonates is an ongoing challenge. Init...
BACKGROUND: Usual treatment regimens with vancomycin often fail to provide adequate serum levels in ...
To access publisher's full text version of this article click on the hyperlink belowAim: Vancomycin ...
Despite the need for effective vancomycin therapy, there are few data guiding vancomycin monitoring ...
Background: Vancomycin is used primarily for Gram-positive infections. Recommended dosage regimens a...
Background: Vancomycin is widely prescribed to treat infections caused by methicillin-resistant Stap...
Monitoring of vancomycin trough concentrations is recommended for pediatric patients in the product ...
ABSTRACT Objective Analyze the microbiological effectiveness, based on the pharmacokinetics/pharma...
OBJECTIVE: To describe the relationships between dosing strategy, age, and vancomycin trough concent...
Background: Vancomycin is widely used to treat infections caused by methicillin-resistant Staphyloco...
AIMS: Vancomycin is frequently used in critically ill children in whom the drug pharmacokinetics are...
Class of 2021 Abstract, Report and PosterSpecific Aims: To determine the intrapatient difference in ...
Vancomycin is a first‐line treatment for β‐lactam‐resistant Gram‐positive bacterial infections. Unde...
Study Objectives To determine whether a relationship exists between initial serum vancomycin trough ...
Artículo de publicación SciELOBackground: In critically ill pediatric patients vancomycin distributi...
BACKGROUND Achieving therapeutic vancomycin concentrations in neonates is an ongoing challenge. Init...
BACKGROUND: Usual treatment regimens with vancomycin often fail to provide adequate serum levels in ...
To access publisher's full text version of this article click on the hyperlink belowAim: Vancomycin ...
Despite the need for effective vancomycin therapy, there are few data guiding vancomycin monitoring ...
Background: Vancomycin is used primarily for Gram-positive infections. Recommended dosage regimens a...
Background: Vancomycin is widely prescribed to treat infections caused by methicillin-resistant Stap...
Monitoring of vancomycin trough concentrations is recommended for pediatric patients in the product ...
ABSTRACT Objective Analyze the microbiological effectiveness, based on the pharmacokinetics/pharma...
OBJECTIVE: To describe the relationships between dosing strategy, age, and vancomycin trough concent...
Background: Vancomycin is widely used to treat infections caused by methicillin-resistant Staphyloco...
AIMS: Vancomycin is frequently used in critically ill children in whom the drug pharmacokinetics are...
Class of 2021 Abstract, Report and PosterSpecific Aims: To determine the intrapatient difference in ...
Vancomycin is a first‐line treatment for β‐lactam‐resistant Gram‐positive bacterial infections. Unde...
Study Objectives To determine whether a relationship exists between initial serum vancomycin trough ...
Artículo de publicación SciELOBackground: In critically ill pediatric patients vancomycin distributi...
BACKGROUND Achieving therapeutic vancomycin concentrations in neonates is an ongoing challenge. Init...
BACKGROUND: Usual treatment regimens with vancomycin often fail to provide adequate serum levels in ...
To access publisher's full text version of this article click on the hyperlink belowAim: Vancomycin ...